In 564 biopsy-naive men with suspicious MRI lesions, simulated targeted plus index lesion-ipsilateral systematic biopsy was noninferior to targeted plus full 12-core systematic biopsy for clinically significant prostate cancer detection (40.78% vs 42.38%; difference −1.6 points).
Observationaln = 564
Cheng et al. Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial